Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study (SAMURAI)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05327686 |
|
Recruitment Status :
Recruiting
First Posted : April 14, 2022
Last Update Posted : August 1, 2022
|
Sponsor:
NRG Oncology
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
NRG Oncology
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 15, 2028 |
| Estimated Study Completion Date : | June 15, 2032 |